A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on communication apps, based on recent findings.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged fat-burning properties. Followers are encouraged to contact these accounts privately for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and claims of next-day British shipping. Sellers promote the drug there before redirecting customers to WhatsApp for transactions.
Learning About The Experimental Drug
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Professionals Voice Concerns
However, doctors and pharmacists have warned that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could result in users administering products of unknown origin.
Several professionals stated the popularity for retatrutide could be linked to the increasing cost of approved slimming products such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for human use under the British medical regulations.
Several content creators try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, marketing, and customer regulations, potentially leading to fines, prosecution or imprisonment.
Service Response and Material Removal
Based on TikTok, the service has taken down violative material and prohibited related keywords and search suggestions. The company said it was committed to maintaining the platform safe and investing in enhancing compliance measures.
Digital Marketplace Operations
Investigations also found groups with up to nine thousand members marketing retatrutide using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up groups with numerous of users, populated with images of weight loss, glowing testimonials and step-by-step guides for mixing or administering at home.
Within moments of entering one group, a vendor posted WhatsApp details, where most purchases occur. The seller sent an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about weight, health issues or previous experience.
Item Details and Costs
Within these communities, posts show dark colored parcels with postal service stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled pens typically sold at £160 for 20mg. When asked how long a pen should last, vendors give conflicting answers ranging from a several days to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for Telegram stated it actively monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering materials they can’t verify. Although the research behind this drug is valid, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are using online platforms. But fake treatments are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.
Her team has previously encountered individuals harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may subject patients to possibly significant medical dangers”.
